Here are five facts:
1. The shares had a 6 percent decrease in trading volume from the previous session’s volume of 87,502 shares.
2. Zacks analysts upgraded the shares from a “hold” rating to a “buy” rating on Nov. 30.
3. The market cap is approximately $740.6 million.
4. Orthofix has a 50-day moving average of $39.42.
5. The 200-day moving average is $36.15.
More articles on orthopedics:
Dr. Mark Mudano opens office at Effingham Health System: 3 points
High risk of wrist tendonitis for new parents — 4 things to know
Distracted walking causes more injuries and hospital visits — 5 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
